CHA AI Healthkare Co.,Ltd.

CHA AI Healthkare Co.,Ltd.

KKRX:025620
5,440.00
KRW
-40.00
(-0.73%)
499.55EPS
13.62P/E
128.99BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1,138,916.55
3,248.87
42,352.42
83,653.88
76,329.95
72,931.06
28,576.28
10,814.24
5,101.37
2,211.24
3,695.1
3,503.89
966.02
539.05
Basic EPS, GAAP
-630,429.69
-3,931.56
-81,920.49
12,578.48
16,121.69
-682.67
-45,840.62
-7,712.73
-13,134.86
-7,588.09
-1,561
-2,122
180.75
520.52
Free Cash Flow per Basic Share
-62,913.15
-2,452.42
-87,119.31
-5,881.05
-35,902.79
-22,369.42
1,510.23
-1,931.97
-3,264.88
-4,590.56
-2,355.74
-1,599.92
-966.89
-391.47
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
125,963.13
35,697.9
22,971.93
58,276.13
70,468.49
69,995.36
27,693.56
23,993.94
16,067.51
10,835.53
8,939.76
6,626.73
4,146.62
4,451.99
Tangible Book Value per Share
125,194.04
35,692
20,560.81
53,564.87
66,210.07
65,779.47
27,288.2
20,651.31
14,117.83
10,793.76
8,867.05
6,584.29
4,104.62
4,411.91
Basic Weighted Avg Shares
- -
2
- -
1
2
2
2
3
3
3
4
4
8
16
Sales/Revenue/Turnover
30,095
7,149
8,011
83,424
129,713
132,015
52,619
30,519
14,978
6,246
16,089
15,675
7,305
8,435
Operating Margin (%)
-42.57
-282.08
-134.06
15.99
17.19
5.41
-98.85
-37.14
-97.55
-127.76
-56.39
-30.95
-97.25
-82.58
Depreciation Expense
1,124
1,602
681
265
846
1,871
3,885
1,610
1,743
952
560
567
755
849
Net Income, GAAP
-16,658
-8,651
-15,496
12,544
27,397
-1,236
-84,408
-21,766
-38,564
-21,435
-6,797
-9,493
1,367
8,145
Effective Tax Rate (%)
- -
- -
- -
- -
- -
533.28
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-55.35
-121.01
-193.43
15.04
21.12
-0.94
-160.41
-71.32
-257.48
-343.16
-42.25
-60.56
18.71
96.56
Working Capital
-22,918
-5,397
11,299
58,406
59,393
95,839
-13,320
-8,950
7,598
15,917
10,391
3,826
16,598
-16,793
LT Debt
6,600
- -
3,296
- -
8,000
35,782
2,008
1,082
469
387
174
369
668
273
Total Equity
3,387
20,085
13,049
86,419
126,998
126,633
53,253
59,827
60,136
41,581
39,987
29,636
75,427
80,997
Return on Invested Capital (%)
- -
- -
- -
- -
- -
-18.46
- -
- -
- -
- -
- -
- -
-10.72
- -
Return on Capital (%)
- -
- -
- -
- -
- -
-4.27
- -
- -
- -
- -
- -
- -
3.48
- -
Return on Common Equity (%)
-199.29
-72.6
-93.54
25.22
25.67
-0.98
-93.55
-37.83
-63.88
-42.29
-16.66
-27.26
2.6
13.48

Capital Structure

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
29,897
28,323
40,462
LT Borrowings
- -
- -
- -
LT Finance Leases
668
337
273
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
18
18
18
Market Capitalization
193,943
163,741
128,992

Working Capital

KRW

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
50,751
44,954
23,612
Cash, Cash Equivalents & STI
42,040
35,497
15,258
Accounts Receivable, Net
1,226
862
758
Inventories
2,974
3,164
3,064
Total Current Liabilities
34,153
37,115
40,405
Payables & Accruals
- -
- -
- -
ST Debt
29,897
28,323
40,462
Deferred Revenue
- -
- -
- -

Growth Rates

KRW

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
65.78%
18.89%
154.51%
Free Cash Flow
50.14%
12.42%
2.15%
Net Income, GAAP
637.91%
-22.05%
-114.4%
Sales/Revenue/Turnover
88.88%
-1.52%
-53.4%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
5,318
5,160
2,701
2,496
15,675
2025
1,751
1,965
1,626
1,963
7,305
2026
1,937
2,909
- -
- -
- -

Quarterly Earnings Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-93
-255
-933
-841.65
-2,122
2025
-528
247
-271.54
250.83
180.75
2026
-255.14
572
- -
- -
- -

Quarterly Dividends Per Share

KRW

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Byeong-Cheol Ko
Full Time Employees
44
Sector
Retail trade
Industry
Specialty stores
Address
52 Seobinggo-ro 51-gil Seoul SL South Korea 04384
IPO Date
Jul 8, 1995
Website
jayjun.kr
Business
Jayjun Cosmetic Co., Ltd. manufactures and distributes cosmetic products primarily in South Korea. The company offers facial care products including mask packs such as black water glow masks and intensive shining masks, eye gel patches like green tea and roselle tea variants, skincare items comprising toners, mists, pads, ampoules, serums, essences, lotions, emulsions, creams, gels, cleansing and peeling solutions, sun care, and beauty accessories; makeup products; collagen jelly and related items; as well as specialized lines for skin cell texture improvement, moisture and moisturizing, whitening and brightening, sensitive and calming care, nutritional elasticity, anti-aging, trouble care, and UV protection. It operates through three segments: Cosmetics, Entertainment and Advertising encompassing record and music businesses, performances, management services, and advertising agencies, and Medical Devices. Founded in 1972 and headquartered in Seoul, South Korea, the company conducts geographic operations in South Korea, China, and the United States. Recent developments include receiving KRW 2.5 billion in funding from NS ENM Co., Ltd. in 2024 and expecting KRW 40 billion in additional funding as announced in March 2025, alongside issuances of convertible bonds and rights offerings in 2025, a CEO change to Byung-Cheol Koh in 2023, and full-year 2024 earnings reported in March 2025.